15 Jul Emmecell
Posted at 17:29h
in
Ramin Valian, CEO
Oct. 5 | 9:45am | FLW Ballroom G
Menlo Park, CA
(Private)
Emmecell is a clinical-stage biotechnology company developing magnetic cell delivery technologies to treat corneal endothelial disease, geographic atrophy, and other ophthalmic conditions. Its platform enables controlled, targeted positioning of therapeutic cells to support minimally invasive, regenerative alternatives to traditional surgical and pharmacologic therapies. Emmecell is headquartered in Menlo Park, California.